AllStripes Information

AllStripes was a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. We helped bridge the gap between the biopharmaceutical industry and families with rare diseases by finding "needle-in-a-haystack" patients, consenting them, acquiring their full medical records, and structuring complex clinical data for various FDA-grade applications. We consented 4,000 families to do research and advanced research with customers such as Novartis, Ultragenyx, UCB, Penn Orphan Disease Center, and many others. We're proud to have demonstrated to the drug industry that when research is truly patient-centered, it is not only more credible and reliable but also transformative--unlocking richer insights and creating a more holistic understanding of the patient experience. AllStripes raised $67m in total and grew to over 100 employees before downsizing and being acquired by PicnicHealth in 2023.